Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer

Gan to Kagaku ryoho. Cancer & Chemotherapy, 2006 - europepmc.org
Background The objective of this study was to evaluate the efficacy and toxicity of gefitinib as
a first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Methods …
被引用次数：4 相关文章

Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer

T Hashizume, T Ogura, S Kozawa… - Gan to kagaku …, 2006 - pubmed.ncbi.nlm.nih.gov
Background The objective of this study was to evaluate the efficacy and toxicity of gefitinib as
a first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Methods …